Water-Soluble Cannabinoid Extracts for Diverse Applications

Publication ID: 24-11857589_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Water-Soluble Cannabinoid Extracts for Diverse Applications,” Published Technical Disclosure No. 24-11857589_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857589_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,589.

Summary of the Inventive Concept

The inventive concept expands the core technology of water-soluble, powdered cannabinoid and/or terpene extracts to various industries, including cosmetics, veterinary care, pharmaceuticals, food additives, and transdermal patches, offering novel solutions for skin care, anxiety disorders, and more.

Background and Problem Solved

The original patent disclosed a water-soluble, powdered cannabinoid and/or terpene extract, but its application was limited to pharmaceuticals. The new inventive concept addresses the need for adapting this technology to other industries, where the benefits of cannabinoids and terpenes can be leveraged to create innovative products and solutions.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of applications, including incorporating the water-soluble, powdered cannabinoid and/or terpene extract into cosmetic products for skin care, developing systems for delivering the extract in veterinary applications, creating compositions for treating anxiety disorders in humans, preparing food additives using the extract, and designing devices for administering the extract through transdermal patches. Each application leverages the unique properties of the extract to provide novel benefits and solutions.

Novelty and Inventive Step

The new claims introduce non-obvious and novel applications of the water-soluble, powdered cannabinoid and/or terpene extract, expanding its use beyond pharmaceuticals and into diverse industries. The inventive concept's novelty lies in the unexpected yet effective adaptation of the extract to address specific problems in these new fields.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of cannabinoids or terpenes, varying the ratios of these compounds, or incorporating additional ingredients to enhance the extract's effects. Variations of the cosmetic product could include different moisturizers, emollients, or anti-inflammatory agents. The veterinary application could be adapted for different species or conditions. The composition for treating anxiety disorders could be modified to include other therapeutic agents.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across multiple industries, including cosmetics, veterinary care, pharmaceuticals, food additives, and transdermal patches. The market for these applications is substantial, with growing demand for innovative, cannabinoid-based products and solutions. The inventive concept's adaptability and versatility make it an attractive opportunity for companies seeking to expand their product offerings and enter new markets.

CPC Classifications

SectionClassGroup
A A61 A61K36/185
A A61 A61K9/107
A A61 A61K47/02
A A61 A61K47/36
A A61 A61K47/40
A A61 A61K47/44

Field of Art

Pharmaceutical and nutraceutical formulation technologies, specifically cannabinoid extraction and delivery systems, involving advanced materials science, drug delivery mechanisms, and biotechnology

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or biotechnology, possessing expertise in drug formulation, extraction techniques, and materials modification, with working knowledge of cannabinoid pharmacology and delivery systems

Obviousness Rationale

A PHOSITA would recognize that the source patent's water-soluble cannabinoid extraction method provides a fundamental platform for diverse applications across multiple industries. The PTD's variations represent predictable extensions of the core technology by applying known formulation principles to different delivery contexts. The technical foundation established in the source patent inherently suggests adaptability to cosmetic, veterinary, pharmaceutical, and transdermal applications through standard pharmaceutical engineering techniques.

Obvious Combinations & Variations

Source Patent Element
Water-soluble, micronized cannabinoid extract complexed with cyclodextrin
PTD Variation
Incorporating extract into cosmetic products with moisturizers and anti-inflammatory agents
Obviousness Reasoning
Known techniques for incorporating active pharmaceutical ingredients into topical formulations, with predictable enhancement of skin care properties
Source Patent Element
Powdered extract loaded onto mesoporous silica
PTD Variation
Developing transdermal patch delivery system with adhesive layer and extract reservoir
Obviousness Reasoning
Standard pharmaceutical engineering approach for modifying drug delivery mechanisms using established materials science principles
Source Patent Element
Emulsification using maltodextrin and acacia
PTD Variation
Creating veterinary application with powdered mixture and liquid carrier
Obviousness Reasoning
Routine adaptation of extraction and emulsification techniques to veterinary pharmaceutical contexts
Source Patent Element
Cannabinoid extract with variable bulk density
PTD Variation
Preparing food additives suitable for human consumption
Obviousness Reasoning
Predictable extension of extraction technology into nutraceutical applications using standard food science formulation methods
Source Patent Element
Cannabinoid receptor interaction mechanism
PTD Variation
Composition for treating anxiety disorders by combining extract with serotonin reuptake inhibitors
Obviousness Reasoning
Logical pharmaceutical combination based on known neurological interaction principles and standard drug development strategies
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would have been obvious to a person having ordinary skill in the art at the time of invention, as they represent predictable extensions of the foundational technology disclosed in US Patent 11857589, utilizing standard pharmaceutical engineering techniques to adapt a core cannabinoid extraction method across diverse application domains.

Original Patent Information

Patent NumberUS 11,857,589
TitleWater-soluble, powdered cannabinoid and/or terpene extract
Assignee(s)MEDPHARM HOLDINGS, LLC